Literature DB >> 32618511

The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.

Lindsey Dugaucquier1, Eline Feyen1, Ligia Mateiu2, Tine Anne Marie Bruyns1, Gilles W De Keulenaer1,3, Vincent F M Segers1,4.   

Abstract

Neuregulin-1 (NRG1) is a paracrine growth factor, secreted by cardiac endothelial cells (ECs) in conditions of cardiac overload/injury. The current concept is that the cardiac effects of NRG1 are mediated by activation of erythroblastic leukemia viral oncogene homolog (ERBB)4/ERBB2 receptors on cardiomyocytes. However, recent studies have shown that paracrine effects of NRG1 on fibroblasts and macrophages are equally important. Here, we hypothesize that NRG1 autocrine signaling plays a role in cardiac remodeling. We generated EC-specific Erbb4 knockout mice to eliminate endothelial autocrine ERBB4 signaling without affecting paracrine NRG1/ERBB4 signaling in the heart. We first observed no basal cardiac phenotype in these mice up to 32 wk. We next studied these mice following transverse aortic constriction (TAC), exposure to angiotensin II (ANG II), or myocardial infarction in terms of cardiac performance, myocardial hypertrophy, myocardial fibrosis, and capillary density. In general, no major differences between EC-specific Erbb4 knockout mice and control littermates were observed. However, 8 wk following TAC both myocardial hypertrophy and fibrosis were attenuated by EC-specific Erbb4 deletion, albeit these responses were normalized after 20 wk. Similarly, 4 wk after ANG II treatment, myocardial fibrosis was less pronounced compared with control littermates. These observations were supported by RNA-sequencing experiments on cultured endothelial cells showing that NRG1 controls the expression of various hypertrophic and fibrotic pathways. Overall, this study shows a role of endothelial autocrine NRG1/ERBB4 signaling in the modulation of hypertrophic and fibrotic responses during early cardiac remodeling. This study contributes to understanding the spatiotemporal heterogeneity of myocardial autocrine and paracrine responses following cardiac injury.NEW & NOTEWORTHY The role of NRG1/ERBB signaling in endothelial cells is not completely understood. Our study contributes to the understanding of spatiotemporal heterogeneity of myocardial autocrine and paracrine responses following cardiac injury and shows a role of endothelial autocrine NRG1/ERBB4 signaling in the modulation of hypertrophic and fibrotic responses during early cardiac remodeling.

Entities:  

Keywords:  ERBB4; cardiac remodeling; endothelium; neuregulin-1

Mesh:

Substances:

Year:  2020        PMID: 32618511     DOI: 10.1152/ajpheart.00176.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

Review 1.  Guidelines for in vivo mouse models of myocardial infarction.

Authors:  Merry L Lindsey; Keith R Brunt; Jonathan A Kirk; Petra Kleinbongard; John W Calvert; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Dominic P Del Re; Nikolaos G Frangogiannis; Stefan Frantz; Richard J Gumina; Ganesh V Halade; Steven P Jones; Rebecca H Ritchie; Francis G Spinale; Edward B Thorp; Crystal M Ripplinger; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-08       Impact factor: 5.125

2.  Autocrine Signaling in Cardiac Remodeling: A Rich Source of Therapeutic Targets.

Authors:  Vincent F M Segers; Gilles W De Keulenaer
Journal:  J Am Heart Assoc       Date:  2021-01-20       Impact factor: 5.501

Review 3.  Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?

Authors:  Lauriane Cornuault; Paul Rouault; Cécile Duplàa; Thierry Couffinhal; Marie-Ange Renault
Journal:  Front Physiol       Date:  2022-07-08       Impact factor: 4.755

Review 4.  Neuregulin-1, a potential therapeutic target for cardiac repair.

Authors:  Yan Wang; Jianliang Wei; Peng Zhang; Xin Zhang; Yifei Wang; Wenjing Chen; Yanan Zhao; Xiangning Cui
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

5.  The chicken, the egg, and the elephant: eNOS and NRG1 in fibrosis.

Authors:  Shamama Nishat; Richard J Gumina
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-25       Impact factor: 5.125

Review 6.  The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases.

Authors:  Sujoita Sen; Logan Hallee; Chi Keung Lam
Journal:  J Pers Med       Date:  2021-12-04

7.  Identification of inflammation-related DNA methylation biomarkers in periodontitis patients based on weighted co-expression analysis.

Authors:  Pengcheng Wang; Bingbing Wang; Zheng Zhang; Zuomin Wang
Journal:  Aging (Albany NY)       Date:  2021-08-04       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.